Penta-O-galloyl-beta-D-glucose induces S- and G(1)-cell cycle arrests in prostate cancer cells targeting DNA replication and cyclin D1
- PMID: 19269999
- PMCID: PMC2675654
- DOI: 10.1093/carcin/bgp059
Penta-O-galloyl-beta-D-glucose induces S- and G(1)-cell cycle arrests in prostate cancer cells targeting DNA replication and cyclin D1
Abstract
We have recently shown that penta-1,2,3,4,6-O-galloyl-beta-D-glucose (PGG), a naturally occurring hydrolyzable gallotannin, inhibited the in vivo growth of human androgen-independent p53-mutant DU145 prostate cancer (PCa) xenograft in athymic nude mice without adverse effect on their body weight. We have also shown that PGG induced caspase-mediated apoptosis in the DU145 cells and the androgen-dependent human p53-wild-type LNCaP cells. Here, we investigated the cell cycle effects of PGG in these and other PCa cells. Our data show that treatment with subapoptotic doses of PGG induced S-arrest, whereas higher doses of PGG induced not only S-arrest but also G(1) arrest. We show, for the first time, that irrespective of the p53 functional status of the PCa cell lines, PGG exerted a rapid (within 2 h) and potent inhibition (inhibitory concentration by 50% approximately 6 microM) of 5-bromo-2'-deoxyuridine incorporation into S phase cells. In isolated nuclei, PGG inhibited DNA replicative synthesis with superior efficacy than a known DNA polymerase alpha inhibitor, aphidocolin. In addition to the S-arrest action, we have found a close association of downregulation of cyclin D1 with G(1) arrest induced by PGG. Overexpressing this G(1) cyclin abolished G(1) arrest, but hastened the S-arrest induction by PGG. Together, our data indicate that PGG induced PCa S-arrest probably through DNA replicative blockage and induced G(1) arrest via cyclin D1 downregulation to contribute to anticancer activity. Our data raise the hypothesis that PGG may be a novel inhibitor of DNA polymerases.
Figures






Similar articles
-
Penta-O-galloyl-beta-D-glucose induces G1 arrest and DNA replicative S-phase arrest independently of cyclin-dependent kinase inhibitor 1A, cyclin-dependent kinase inhibitor 1B and P53 in human breast cancer cells and is orally active against triple negative xenograft growth.Breast Cancer Res. 2010;12(5):R67. doi: 10.1186/bcr2634. Epub 2010 Sep 1. Breast Cancer Res. 2010. PMID: 20809980 Free PMC article.
-
Penta-1,2,3,4,6-O-galloyl-beta-D-glucose induces p53 and inhibits STAT3 in prostate cancer cells in vitro and suppresses prostate xenograft tumor growth in vivo.Mol Cancer Ther. 2008 Sep;7(9):2681-91. doi: 10.1158/1535-7163.MCT-08-0456. Mol Cancer Ther. 2008. PMID: 18790750
-
Anti-cancer gallotannin penta-O-galloyl-beta-D-glucose is a nanomolar inhibitor of select mammalian DNA polymerases.Biochem Pharmacol. 2010 Oct 15;80(8):1125-32. doi: 10.1016/j.bcp.2010.06.031. Epub 2010 Jun 26. Biochem Pharmacol. 2010. PMID: 20599777 Free PMC article.
-
Anti-cancer, anti-diabetic and other pharmacologic and biological activities of penta-galloyl-glucose.Pharm Res. 2009 Sep;26(9):2066-80. doi: 10.1007/s11095-009-9932-0. Epub 2009 Jul 2. Pharm Res. 2009. PMID: 19575286 Free PMC article. Review.
-
Biological and biomedical functions of Penta-O-galloyl-D-glucose and its derivatives.J Nat Med. 2014 Jul;68(3):465-72. doi: 10.1007/s11418-014-0823-2. Epub 2014 Feb 15. J Nat Med. 2014. PMID: 24532420 Review.
Cited by
-
Galbanic acid decreases androgen receptor abundance and signaling and induces G1 arrest in prostate cancer cells.Int J Cancer. 2012 Jan 1;130(1):200-12. doi: 10.1002/ijc.25993. Epub 2011 May 9. Int J Cancer. 2012. PMID: 21328348 Free PMC article.
-
Penta-O-galloyl-beta-D-glucose induces G1 arrest and DNA replicative S-phase arrest independently of cyclin-dependent kinase inhibitor 1A, cyclin-dependent kinase inhibitor 1B and P53 in human breast cancer cells and is orally active against triple negative xenograft growth.Breast Cancer Res. 2010;12(5):R67. doi: 10.1186/bcr2634. Epub 2010 Sep 1. Breast Cancer Res. 2010. PMID: 20809980 Free PMC article.
-
Pentagalloylglucose induces autophagy and caspase-independent programmed deaths in human PC-3 and mouse TRAMP-C2 prostate cancer cells.Mol Cancer Ther. 2009 Oct;8(10):2833-43. doi: 10.1158/1535-7163.MCT-09-0288. Mol Cancer Ther. 2009. PMID: 19825802 Free PMC article.
-
The H6D variant of NAG-1/GDF15 inhibits prostate xenograft growth in vivo.Prostate. 2012 May 1;72(6):677-89. doi: 10.1002/pros.21471. Epub 2011 Aug 1. Prostate. 2012. PMID: 21809352 Free PMC article.
-
The genome-wide expression profile of 1,2,3,4,6-penta-O-galloyl-β-D-glucose-treated MDA-MB-231 breast cancer cells: molecular target on cancer metabolism.Mol Cells. 2011 Aug;32(2):123-32. doi: 10.1007/s10059-011-2254-1. Epub 2011 May 24. Mol Cells. 2011. PMID: 21614488 Free PMC article.
References
-
- Lambert JD, et al. Inhibition of carcinogenesis by polyphenols: evidence from laboratory investigations. Am. J. Clin. Nutr. 2005;81:284S–291S. - PubMed
-
- Singh RP, et al. Mechanisms of action of novel agents for prostate cancer chemoprevention. Endocr. Relat. Cancer. 2006;13:751–778. - PubMed
-
- Hu H, et al. Penta-1,2,3,4,6-O-galloyl-beta-D-glucose induces p53 and inhibits STAT3 in prostate cancer cells in vitro and suppresses prostate xenograft tumor growth in vivo. Mol. Cancer Ther. 2008;7:2681–2691. - PubMed
-
- Pan MH, et al. Induction of apoptosis by penta-O-galloyl-beta-D-glucose through activation of caspase-3 in human leukemia HL-60 cells. Eur. J. Pharmacol. 1999;381:171–183. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous